Sökresultat - Isabel Redondo

  • Visas 1 - 9 av 9 resultat
Förfina resultatet
  1. 1
    New Method for Obtaining a Bioactive Essence Extracted from Iberian Ham Fat Rich in MUFA and Antioxidants

    New Method for Obtaining a Bioactive Essence Extracted from Iberian Ham Fat Rich in MUFA and Antioxidants av Bruna-García, Eva, Isabel Redondo, Beatriz, Miguel Castro, Marta

    Publicerad 2022
    Hämta fulltext Hämta fulltext Hämta fulltext
    Text
    Lägg till i favoriter
    Sparad:
  2. 2
    Efficacy and Safety of Advanced Therapies in Moderately-to-Severely Active Ulcerative Colitis: a Systematic Review and Network Meta-analysis

    Efficacy and Safety of Advanced Therapies in Moderately-to-Severely Active Ulcerative Colitis: a Systematic Review and Network Meta-analysis av Axel Dignaß, Claire Ainsworth, Susanne Hartz, Niels Dunnewind, Isabel Redondo, Christophe Sapin, Sonja Kroep, N. Halfpenny, Emanuele Arcà, Sami Hoque

    Publicerad 2024
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  3. 3
    Patient and Health Care Professional Perspectives on the Burden and Daily Life Impact of Ulcerative Colitis and Crohn’s Disease: Results from the Japanese CONFIDE Study

    Patient and Health Care Professional Perspectives on the Burden and Daily Life Impact of Ulcerative Colitis and Crohn’s Disease: Results from the Japanese CONFIDE Study av Toshifumi Hibi∥, Taku Kobayashi, Masaru Tanaka, Satoshi Osaga, Alison Potts Bleakman, Theresa Hunter, Marijana Protić, Isabel Redondo, Koji Matsuo, Tadakazu Hisamatsu

    Publicerad 2025
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  4. 4
    A diet based on cured acorn-fed ham with oleic acid content promotes anti-inflammatory gut microbiota and prevents ulcerative colitis in an animal model

    A diet based on cured acorn-fed ham with oleic acid content promotes anti-inflammatory gut microbiota and prevents ulcerative colitis in an animal model av Javier Fernández, Vanessa García de la Fuente, María Teresa Fernández García, Javier Gómez Sánchez, Beatriz Isabel Redondo, Claudio J. Villar, Felipe Lombó

    Publicerad 2020
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  5. 5
    Resolving Histological Inflammation in Ulcerative Colitis With Mirikizumab in the LUCENT Induction and Maintenance Trial Programmes

    Resolving Histological Inflammation in Ulcerative Colitis With Mirikizumab in the LUCENT Induction and Maintenance Trial Programmes av Fernando Magro, Rish K. Pai, Taku Kobayashi, Vipul Jairath, Florian Rieder, Isabel Redondo, Trevor Lissoos, Nathan Morris, Mingyang Shan, Meekyong Park, Laurent Peyrin–Biroulet

    Publicerad 2023
    Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  6. 6
    Bowel Urgency in Ulcerative Colitis: Current Perspectives and Future Directions

    Bowel Urgency in Ulcerative Colitis: Current Perspectives and Future Directions av Marla C. Dubinsky, Alison Potts Bleakman, Remo Panaccione, Toshifumi Hibi∥, Stefan Schreiber, David T. Rubin, Axel Dignaß, Isabel Redondo, Theresa Hunter, Cem Kayhan, Simon Travis

    Publicerad 2023
    Hämta fulltext
    Revisão
    Lägg till i favoriter
    Sparad:
  7. 7
    Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT Programme

    Early and Sustained Symptom Control with Mirikizumab in Patients with Ulcerative Colitis in the Phase 3 LUCENT Programme av Silvio Danese, Axel Dignaß, Katsuyoshi Matsuoka, Marc Ferrante, Millie D. Long, Isabel Redondo, Richard Moses, Sebastian Maier, Theresa Hunter, Nathan Morris, Catherine Milch, María T. Abreu

    Publicerad 2024
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  8. 8
    Extended Induction and Prognostic Indicators of Response in Patients Treated with Mirikizumab with Moderately to Severely Active Ulcerative Colitis in the LUCENT Trials

    Extended Induction and Prognostic Indicators of Response in Patients Treated with Mirikizumab with Moderately to Severely Active Ulcerative Colitis in the LUCENT Trials av Geert D’Haens, Peter Higgins, Laurent Peyrin–Biroulet, Bruce E. Sands, Scott D. Lee, Richard Moses, Isabel Redondo, Rodrigo Escobar, Theresa Hunter, Anthony Keohane, Nathan Morris, Xin Zhang, Vipin Arora, Taku Kobayashi

    Publicerad 2024
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:
  9. 9
    Histologic assessments in ulcerative colitis: the evidence behind a new endpoint in clinical trials

    Histologic assessments in ulcerative colitis: the evidence behind a new endpoint in clinical trials av Rish K. Pai, Geert D’Haens, Taku Kobayashi, Bruce E. Sands, Simon Travis, Vipul Jairath, Gert De Hertogh, Bomina Park, Kim McGinnis, Isabel Redondo, Nicole G. Lipitz, Theresa Hunter, Fernando Magro

    Publicerad 2024
    Hämta fulltext Hämta fulltext
    Artigo
    Lägg till i favoriter
    Sparad:

Sökverktyg: